All patients achieved engraftment, and none developed complications associated with COVID-19.
Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.
All articles by Andrea S. Blevins Primeau, PhD, MBA
RSK4-targeting floxacins could boost the efficacy of chemotherapy.
Researchers observed a “sharp” decline in public interest.